Table 3.
Tuberculosis cases, millions
|
Tuberculosis deaths, millions
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
EME | FSE | LAC/MEC | Asia | SSA | World | EME | FSE | LAC/MEC | Asia | SSA | World | |
Total cases, millions | Total deaths, millions | |||||||||||
Baseline DOTS | 3.3 | 2.2 | 15.4 | 136.7 | 66.9 | 224.5 | 0.2 | 0.3 | 4.2 | 46.6 | 27.5 | 78.8 |
Cases averted compared to baseline (millions) | Deaths averted compared to baseline (millions) | |||||||||||
Existing technologies | ||||||||||||
DOTSNeg | * | * | 0.1 | 1.3 | 0.3 | 1.7 | * | * | 0.1 | 1.3 | 0.4 | 1.9 |
ACF-Sx-1 | 0.02 | 0.07 | 0.7 | 7.2 | 5.6 | 13.6 | 0.01 | 0.02 | 0.3 | 3.1 | 2.7 | 6.1 |
ACF-Sx | 0.04 | 0.11 | 1.3 | 15.9 | 12.9 | 30.3 | 0.01 | 0.03 | 0.5 | 6.8 | 5.9 | 13.3 |
ACF-MMR-1 | 0.04 | 0.13 | 1.3 | 12.9 | 10.1 | 24.4 | 0.01 | 0.04 | 0.5 | 5.8 | 5.0 | 11.4 |
ACF-MMR | 0.07 | 0.19 | 2.2 | 26.1 | 20.5 | 49.1 | 0.02 | 0.05 | 0.9 | 11.7 | 9.9 | 22.6 |
MassPT | 0.10 | 0.16 | 2.8 | 24.5 | 15.0 | 42.6 | 0.01 | 0.04 | 0.8 | 9.1 | 6.7 | 16.7 |
PTHIV5 | 0.00 | 0.00 | 0.1 | 0.5 | 0.6 | 1.2 | 0.00 | 0.00 | 0.0 | 0.2 | 0.3 | 0.5 |
PTHIV10 | 0.00 | 0.00 | 0.1 | 0.8 | 1.0 | 1.9 | 0.00 | 0.00 | 0.0 | 0.3 | 0.5 | 0.8 |
New technologies | ||||||||||||
Smear75 | * | * | 0.1 | 0.8 | 1.0 | 1.9 | * | * | 0.2 | 1.0 | 1.4 | 2.6 |
Smear95 | * | * | 0.2 | 1.4 | 1.9 | 3.6 | * | * | 0.3 | 1.8 | 2.6 | 4.7 |
UltraSCC | 0.00 | 0.04 | 0.6 | 18.8 | 4.3 | 23.8 | 0.00 | 0.01 | 0.3 | 8.2 | 2.1 | 10.7 |
VacBr20 | 0.03 | 0.03 | 0.6 | 10.1 | 5.4 | 16.2 | 0.00 | 0.00 | 0.1 | 2.4 | 1.6 | 4.1 |
VacBr50 | 0.07 | 0.08 | 1.4 | 22.6 | 12.1 | 36.1 | 0.00 | 0.01 | 0.3 | 5.6 | 3.5 | 9.4 |
VacBr80 | 0.10 | 0.12 | 2.0 | 32.3 | 17.1 | 51.6 | 0.01 | 0.01 | 0.4 | 8.1 | 5.1 | 13.7 |
VacInf20 | 0.02 | 0.02 | 0.4 | 6.6 | 3.4 | 10.5 | 0.00 | 0.00 | 0.1 | 1.6 | 1.0 | 2.7 |
VacInf50 | 0.05 | 0.05 | 0.9 | 15.4 | 8.0 | 24.5 | 0.00 | 0.00 | 0.2 | 3.8 | 2.3 | 6.3 |
VacInf80 | 0.07 | 0.08 | 1.5 | 23.2 | 12.2 | 37.0 | 0.00 | 0.01 | 0.3 | 5.8 | 3.6 | 9.6 |
Combination strategies | ||||||||||||
ACF-MMR + MassPT | 0.13 | 0.23 | 3.7 | 36.4 | 24.4 | 64.8 | 0.02 | 0.06 | 1.2 | 14.4 | 11.1 | 26.7 |
ACF-MMR + VacBr50 | 0.12 | 0.25 | 3.1 | 39.8 | 25.5 | 68.7 | 0.02 | 0.06 | 1.0 | 14.8 | 11.2 | 27.1 |
ACF-MMR + UltraSCC | 0.08 | 0.23 | 2.8 | 44.2 | 24.6 | 71.8 | 0.02 | 0.06 | 1.1 | 19.0 | 11.7 | 32.0 |
Smear95 + UltraSCC | 0.00 | 0.04 | 0.8 | 19.3 | 6.0 | 26.2 | 0.00 | 0.01 | 0.5 | 9.0 | 4.4 | 13.9 |
Indicates no averted cases or deaths over baseline. Cells containing 0.0 indicate >0 but <5,000 cases or deaths averted.